A seroepidemiologic study of a measles outbreak, Yamagata Prefecture, Japan, 2017: The estimation of spreaders using serological assays in a measles elimination setting
In regions where the endemic measles virus has been eliminated, early detection of contagious patients is important for preventing the spread of measles and sustaining elimination. To investigate whether serological assays can be used for the estimation of highly infectious patients with measles, we...
Saved in:
Published in | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy Vol. 28; no. 7; pp. 1018 - 1022 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
01.07.2022
|
Subjects | |
Online Access | Get full text |
ISSN | 1341-321X 1437-7780 1437-7780 |
DOI | 10.1016/j.jiac.2022.03.025 |
Cover
Loading…
Abstract | In regions where the endemic measles virus has been eliminated, early detection of contagious patients is important for preventing the spread of measles and sustaining elimination. To investigate whether serological assays can be used for the estimation of highly infectious patients with measles, we performed a seroepidemiologic study of a measles outbreak in Yamagata Prefecture, Japan, in 2017.
We tested plaque reduction neutralization (PRN), IgG avidity, and gelatin particle agglutination (PA) assays in 31 patients with measles, subdivided into two super-spreaders, three spreaders, and 26 non-spreaders. Simultaneously, these results were compared with the cycle threshold (Ct) of a semi-quantitative real-time reverse transcription PCR for the measles virus from throat swab specimens.
In the PRN assay, one super-spreader and two spreaders lacked protective antibodies. The IgG avidity assay showed that two super-spreaders and one spreader had low avidity. The PA assay indicated that two super-spreaders and two spreaders lacked protective antibodies. Comparison of the results of the three serological assays and Ct revealed that patients whose antibody titers were judged as low in the IgG avidity and PA assays showed low Ct (i.e., high viral load), whereas non-spreaders tended to show low viral load.
Our preliminary seroepidemiologic analysis of a population of 31 patients with measles suggests that PA and IgG avidity assays may be used for the identification of super-spreader/spreader candidates. However, further investigations are necessary to validate the robustness of these serological assays in detecting contagious measles cases. |
---|---|
AbstractList | In regions where the endemic measles virus has been eliminated, early detection of contagious patients is important for preventing the spread of measles and sustaining elimination. To investigate whether serological assays can be used for the estimation of highly infectious patients with measles, we performed a seroepidemiologic study of a measles outbreak in Yamagata Prefecture, Japan, in 2017.INTRODUCTIONIn regions where the endemic measles virus has been eliminated, early detection of contagious patients is important for preventing the spread of measles and sustaining elimination. To investigate whether serological assays can be used for the estimation of highly infectious patients with measles, we performed a seroepidemiologic study of a measles outbreak in Yamagata Prefecture, Japan, in 2017.We tested plaque reduction neutralization (PRN), IgG avidity, and gelatin particle agglutination (PA) assays in 31 patients with measles, subdivided into two super-spreaders, three spreaders, and 26 non-spreaders. Simultaneously, these results were compared with the cycle threshold (Ct) of a semi-quantitative real-time reverse transcription PCR for the measles virus from throat swab specimens.METHODSWe tested plaque reduction neutralization (PRN), IgG avidity, and gelatin particle agglutination (PA) assays in 31 patients with measles, subdivided into two super-spreaders, three spreaders, and 26 non-spreaders. Simultaneously, these results were compared with the cycle threshold (Ct) of a semi-quantitative real-time reverse transcription PCR for the measles virus from throat swab specimens.In the PRN assay, one super-spreader and two spreaders lacked protective antibodies. The IgG avidity assay showed that two super-spreaders and one spreader had low avidity. The PA assay indicated that two super-spreaders and two spreaders lacked protective antibodies. Comparison of the results of the three serological assays and Ct revealed that patients whose antibody titers were judged as low in the IgG avidity and PA assays showed low Ct (i.e., high viral load), whereas non-spreaders tended to show low viral load.RESULTSIn the PRN assay, one super-spreader and two spreaders lacked protective antibodies. The IgG avidity assay showed that two super-spreaders and one spreader had low avidity. The PA assay indicated that two super-spreaders and two spreaders lacked protective antibodies. Comparison of the results of the three serological assays and Ct revealed that patients whose antibody titers were judged as low in the IgG avidity and PA assays showed low Ct (i.e., high viral load), whereas non-spreaders tended to show low viral load.Our preliminary seroepidemiologic analysis of a population of 31 patients with measles suggests that PA and IgG avidity assays may be used for the identification of super-spreader/spreader candidates. However, further investigations are necessary to validate the robustness of these serological assays in detecting contagious measles cases.CONCLUSIONSOur preliminary seroepidemiologic analysis of a population of 31 patients with measles suggests that PA and IgG avidity assays may be used for the identification of super-spreader/spreader candidates. However, further investigations are necessary to validate the robustness of these serological assays in detecting contagious measles cases. In regions where the endemic measles virus has been eliminated, early detection of contagious patients is important for preventing the spread of measles and sustaining elimination. To investigate whether serological assays can be used for the estimation of highly infectious patients with measles, we performed a seroepidemiologic study of a measles outbreak in Yamagata Prefecture, Japan, in 2017. We tested plaque reduction neutralization (PRN), IgG avidity, and gelatin particle agglutination (PA) assays in 31 patients with measles, subdivided into two super-spreaders, three spreaders, and 26 non-spreaders. Simultaneously, these results were compared with the cycle threshold (Ct) of a semi-quantitative real-time reverse transcription PCR for the measles virus from throat swab specimens. In the PRN assay, one super-spreader and two spreaders lacked protective antibodies. The IgG avidity assay showed that two super-spreaders and one spreader had low avidity. The PA assay indicated that two super-spreaders and two spreaders lacked protective antibodies. Comparison of the results of the three serological assays and Ct revealed that patients whose antibody titers were judged as low in the IgG avidity and PA assays showed low Ct (i.e., high viral load), whereas non-spreaders tended to show low viral load. Our preliminary seroepidemiologic analysis of a population of 31 patients with measles suggests that PA and IgG avidity assays may be used for the identification of super-spreader/spreader candidates. However, further investigations are necessary to validate the robustness of these serological assays in detecting contagious measles cases. |
Author | Ikeda, Tatsuya Seto, Junji Aoki, Yoko Komabayashi, Kenichi Mizuta, Katsumi Tanaka, Shizuka |
Author_xml | – sequence: 1 givenname: Junji orcidid: 0000-0003-2227-5315 surname: Seto fullname: Seto, Junji email: setoj@pref.yamagata.jp – sequence: 2 givenname: Yoko surname: Aoki fullname: Aoki, Yoko – sequence: 3 givenname: Shizuka surname: Tanaka fullname: Tanaka, Shizuka – sequence: 4 givenname: Kenichi orcidid: 0000-0003-0900-8845 surname: Komabayashi fullname: Komabayashi, Kenichi – sequence: 5 givenname: Tatsuya surname: Ikeda fullname: Ikeda, Tatsuya – sequence: 6 givenname: Katsumi orcidid: 0000-0001-8965-9925 surname: Mizuta fullname: Mizuta, Katsumi |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35396155$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1u1DAUhS1URH_gBVggL1lMgu3ETlKxqaryp0qwKBKsrBvnZvA0iQfbQZo36mPizLQS6qKs7MX5ztE955QcTW5CQl5zlnPG1btNvrFgcsGEyFmRMyGfkRNeFlVWVTU7Sv-i5Fkh-I9jchrChjFeybp-QY4LWTSKS3lC7i5oQO9wazscrRvc2hoa4tztqOsp0BEhDBiom2PrEW5X9CeMsIYI9JvHHk2cPa7oF9jCtKIiJZzTm19IMUQ7QrRuWnzCNrEd-kDnYKf1PnIfBQOFEGAXqJ3-ScPBjnY64AFjTMxL8ryHIeCr-_eMfP9wdXP5Kbv--vHz5cV1Zsqmilnb8162fWv6HhQD1bGuFEoCZ6wxRrV1YapWVlJKbEsBLa-h64RqoaoaBY0ozsjbg-_Wu99zOkOPNhgcBpjQzUELVdZ1o4RQSfrmXjq3I3Z669PJfqcf2k2C-iAw3oWQ6tLGxv1V0YMdNGd6GVJv9DKkXobUrNBpyISKR-iD-5PQ-wOEqaA_Fr0OxuJksLM-LaU7Z5_Gzx_hZrDTMtIt7v4H_wVFqM1f |
CitedBy_id | crossref_primary_10_1265_jjh_24002 crossref_primary_10_3390_v15010171 |
Cites_doi | 10.2807/1560-7917.ES.2018.23.24.1800239 10.1017/S095026881800211X 10.1128/CVI.00268-16 10.1002/jmv.26733 10.3389/fmicb.2019.01470 10.1128/CVI.00406-12 10.1016/j.vaccine.2019.11.075 10.1093/infdis/162.5.1036 10.7883/yoken.JJID.2018.083 10.1007/s007050050215 |
ContentType | Journal Article |
Copyright | 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases Copyright © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases – notice: Copyright © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.jiac.2022.03.025 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1437-7780 |
EndPage | 1022 |
ExternalDocumentID | 35396155 10_1016_j_jiac_2022_03_025 S1341321X22001040 |
Genre | Journal Article |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GroupedDBID | --- --M -Y2 -~C .1- .55 .86 .FO .~1 0R~ 0VY 1N0 1P~ 1SB 1~. 2.D 28- 29K 2JY 2P1 2VQ 2~H 30V 4.4 408 409 40D 457 4G. 53G 5GY 5QI 5VS 67Z 6NX 7-5 8P~ 8TC 8UJ 95. 95~ AAAJQ AAEDT AAEDW AAIAL AAIKJ AAKOC AALRI AANXM AAOAW AAQFI AARHV AATTM AAXKI AAXUO AAYWO AAYZH ABFSG ABJNI ABMAC ABMNI ABMZM ABQSL ABXDB ACDAQ ACGFS ACIEU ACOMO ACRLP ACSTC ACVFH ADBBV ADCNI ADEZE ADHKG ADIMF ADKPE ADQRH ADRFC ADVLN AEBSH AEFIE AEIPS AEKER AENEX AEUPX AEVXI AEZWR AFBBN AFEXP AFHIU AFLOW AFPUW AFRHN AFTJW AFWTZ AFXIZ AGCQF AGGDS AGHFR AGJBK AGQPQ AGUBO AHBYD AHKAY AHSBF AHWEU AIEXJ AIGII AIIUN AIKHN AITUG AIXLP AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMKLP AMRAJ ANKPU ANZVX ASPBG AVWKF AXJTR AZFZN BA0 BBWZM BGNMA BKOJK BLXMC BNPGV CAG CJTIS COF CS3 CSCUP D-I DL5 EBS EFJIC EFKBS EJD EMOBN EN4 F5P FDB FEDTE FIRID FYGXN GBLVA GQ8 GXS H13 HF~ HG5 HG6 HMJXF HVGLF HZ~ I09 IHE IXC IXE IZIGR IZQ I~X KDC KOM KOW KPH LAS M41 M4Y MA- MO0 N2Q N9A NB0 NDZJH NU0 O9- O93 O9G O9I OAM OAUVE OC~ P-8 P-9 P19 P2P P9S PC. PT5 QOK QOS R4E R89 R9I RNI ROL RPX RRX RSV RZK S1Z S26 S27 S28 S37 S3B SDE SDH SDM SMD SOJ SPCBC SSH SSZ SV3 T13 T16 T5K TSK TSV TT1 TUC U2A VC2 WJK WK8 X7M Z45 Z5R ~A9 ~EX ~G- -5E -5G -BR 0SF AACTN AAIAV ABLVK ABTEG ABYKQ ADINQ AFKWA AFNRJ AHPSJ AJBFU AJOXV AMFUW EFLBG GQ6 NCXOZ RIG SSI SZN Z7U Z82 Z87 Z8O Z8V Z91 AAYXX AFCTW AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c497t-bf1f5bfbcffa60a6d0d4265a1009cc6b83c7b57555eb42ab18add26ba7796a923 |
IEDL.DBID | .~1 |
ISSN | 1341-321X 1437-7780 |
IngestDate | Mon Jul 21 10:47:17 EDT 2025 Thu Apr 03 07:00:11 EDT 2025 Tue Jul 01 02:23:38 EDT 2025 Thu Apr 24 23:03:58 EDT 2025 Fri Feb 23 02:39:46 EST 2024 Tue Aug 26 18:42:30 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Gelatin particle agglutination Vaccine Plaque reduction neutralization IgG avidity Super-spreader |
Language | English |
License | Copyright © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c497t-bf1f5bfbcffa60a6d0d4265a1009cc6b83c7b57555eb42ab18add26ba7796a923 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-2227-5315 0000-0003-0900-8845 0000-0001-8965-9925 |
PMID | 35396155 |
PQID | 2648896226 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_2648896226 pubmed_primary_35396155 crossref_citationtrail_10_1016_j_jiac_2022_03_025 crossref_primary_10_1016_j_jiac_2022_03_025 elsevier_sciencedirect_doi_10_1016_j_jiac_2022_03_025 elsevier_clinicalkey_doi_10_1016_j_jiac_2022_03_025 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | July 2022 2022-07-00 2022-Jul 20220701 |
PublicationDateYYYYMMDD | 2022-07-01 |
PublicationDate_xml | – month: 07 year: 2022 text: July 2022 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy |
PublicationTitleAlternate | J Infect Chemother |
PublicationYear | 2022 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Mizumoto, Kobayashi, Chowell (bib5) 2018; 23 Mercader, Garcia, Bellini (bib9) 2012; 19 Chen, Markowitz, Albrecht, Stewart, Mofenson, Preblud (bib14) 1990; 162 Komabayashi, Seto, Tanaka, Suzuki, Ikeda, Onuki (bib4) 2018; 71 Seki, Miyoshi, Ikeda, Nishijima, Saikusa, Itamochi (bib3) 2019; 10 Sato, Miyamura, Sakae, Kobune, Inouye, Fujino (bib7) 1997; 142 Kurata, Yamamoto, Nishimura, Yumisashi, Motomura, Kinoshita (bib15) 2021; 93 World Health Organization (bib2) 2012 (bib12) 2017 (bib10) 2020 Moss, Griffin (bib1) 2014 Sowers, Rota, Hickman, Mercader, Redd, McNall (bib8) 2016; 23 (bib11) 2021 Kurata, Kanbayashi, Egawa, Kinoshita, Yoshida, Miyazono (bib13) 2020; 38 Seto, Ikeda, Tanaka, Komabayashi, Matoba, Suzuki (bib6) 2018; 146 Moss (10.1016/j.jiac.2022.03.025_bib1) 2014 (10.1016/j.jiac.2022.03.025_bib10) 2020 Mercader (10.1016/j.jiac.2022.03.025_bib9) 2012; 19 (10.1016/j.jiac.2022.03.025_bib11) 2021 (10.1016/j.jiac.2022.03.025_bib12) 2017 Kurata (10.1016/j.jiac.2022.03.025_bib13) 2020; 38 Chen (10.1016/j.jiac.2022.03.025_bib14) 1990; 162 Komabayashi (10.1016/j.jiac.2022.03.025_bib4) 2018; 71 Seki (10.1016/j.jiac.2022.03.025_bib3) 2019; 10 World Health Organization (10.1016/j.jiac.2022.03.025_bib2) 2012 Kurata (10.1016/j.jiac.2022.03.025_bib15) 2021; 93 Sato (10.1016/j.jiac.2022.03.025_bib7) 1997; 142 Mizumoto (10.1016/j.jiac.2022.03.025_bib5) 2018; 23 Seto (10.1016/j.jiac.2022.03.025_bib6) 2018; 146 Sowers (10.1016/j.jiac.2022.03.025_bib8) 2016; 23 |
References_xml | – volume: 142 start-page: 1971 year: 1997 end-page: 1977 ident: bib7 article-title: Development of a gelatin particle agglutination reagent for measles antibody assay publication-title: Arch Virol – year: 2017 ident: bib12 article-title: Laboratory manuals for pathogen detection – volume: 38 start-page: 1467 year: 2020 end-page: 1475 ident: bib13 article-title: A measles outbreak from an index case with immunologically confirmed secondary vaccine failure publication-title: Vaccine – year: 2014 ident: bib1 article-title: Paramyxoviruses: measles publication-title: Viral infections of humans, epidemilogy and control – volume: 23 start-page: 707 year: 2016 end-page: 716 ident: bib8 article-title: High concentrations of measles neutralizing antibodies and high-avidity measles IgG accurately identify measles reinfection cases publication-title: Clin Vaccine Immunol – volume: 71 start-page: 413 year: 2018 end-page: 418 ident: bib4 article-title: The largest measles outbreak, including 38 modified measles and 22 typical measles cases in its elimination era in Yamagata, Japan, 2017 publication-title: Jpn J Infect Dis – volume: 146 start-page: 1707 year: 2018 end-page: 1713 ident: bib6 article-title: Detection of modified measles and super-spreader using a real-time reverse transcription PCR in the largest measles outbreak, Yamagata, Japan, 2017 in its elimination era publication-title: Epidemiol Infect – volume: 93 start-page: 3446 year: 2021 end-page: 3454 ident: bib15 article-title: A measles outbreak in Kansai International Airport, Japan, 2016: analysis of the quantitative difference and infectivity of measles virus between patients who are immunologically naive versus those with secondary vaccine failure publication-title: J Med Virol – volume: 10 start-page: 1470 year: 2019 ident: bib3 article-title: Nationwide molecular epidemiology of measles virus in Japan between 2008 and 2017 publication-title: Front Microbiol – volume: 162 start-page: 1036 year: 1990 end-page: 1042 ident: bib14 article-title: Measles antibody: reevaluation of protective titers publication-title: J Infect Dis – year: 2021 ident: bib11 article-title: Annual Report 2019, National epidemiological surveillance, of vaccine-preventable diseases: measles – year: 2012 ident: bib2 article-title: Global measles and rubella strategic plan 2012-2020 – volume: 23 start-page: 1800239 year: 2018 ident: bib5 article-title: Transmission potential of modified measles during an outbreak, Japan, March‒May 2018 publication-title: Euro Surveill – year: 2020 ident: bib10 article-title: Vaccine guidelines for health care providers – volume: 19 start-page: 1810 year: 2012 end-page: 1817 ident: bib9 article-title: Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings publication-title: Clin Vaccine Immunol – volume: 23 start-page: 1800239 year: 2018 ident: 10.1016/j.jiac.2022.03.025_bib5 article-title: Transmission potential of modified measles during an outbreak, Japan, March‒May 2018 publication-title: Euro Surveill doi: 10.2807/1560-7917.ES.2018.23.24.1800239 – volume: 146 start-page: 1707 year: 2018 ident: 10.1016/j.jiac.2022.03.025_bib6 article-title: Detection of modified measles and super-spreader using a real-time reverse transcription PCR in the largest measles outbreak, Yamagata, Japan, 2017 in its elimination era publication-title: Epidemiol Infect doi: 10.1017/S095026881800211X – year: 2014 ident: 10.1016/j.jiac.2022.03.025_bib1 article-title: Paramyxoviruses: measles – volume: 23 start-page: 707 year: 2016 ident: 10.1016/j.jiac.2022.03.025_bib8 article-title: High concentrations of measles neutralizing antibodies and high-avidity measles IgG accurately identify measles reinfection cases publication-title: Clin Vaccine Immunol doi: 10.1128/CVI.00268-16 – year: 2021 ident: 10.1016/j.jiac.2022.03.025_bib11 – volume: 93 start-page: 3446 year: 2021 ident: 10.1016/j.jiac.2022.03.025_bib15 article-title: A measles outbreak in Kansai International Airport, Japan, 2016: analysis of the quantitative difference and infectivity of measles virus between patients who are immunologically naive versus those with secondary vaccine failure publication-title: J Med Virol doi: 10.1002/jmv.26733 – volume: 10 start-page: 1470 year: 2019 ident: 10.1016/j.jiac.2022.03.025_bib3 article-title: Nationwide molecular epidemiology of measles virus in Japan between 2008 and 2017 publication-title: Front Microbiol doi: 10.3389/fmicb.2019.01470 – year: 2020 ident: 10.1016/j.jiac.2022.03.025_bib10 – year: 2017 ident: 10.1016/j.jiac.2022.03.025_bib12 – volume: 19 start-page: 1810 year: 2012 ident: 10.1016/j.jiac.2022.03.025_bib9 article-title: Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings publication-title: Clin Vaccine Immunol doi: 10.1128/CVI.00406-12 – volume: 38 start-page: 1467 year: 2020 ident: 10.1016/j.jiac.2022.03.025_bib13 article-title: A measles outbreak from an index case with immunologically confirmed secondary vaccine failure publication-title: Vaccine doi: 10.1016/j.vaccine.2019.11.075 – volume: 162 start-page: 1036 year: 1990 ident: 10.1016/j.jiac.2022.03.025_bib14 article-title: Measles antibody: reevaluation of protective titers publication-title: J Infect Dis doi: 10.1093/infdis/162.5.1036 – volume: 71 start-page: 413 year: 2018 ident: 10.1016/j.jiac.2022.03.025_bib4 article-title: The largest measles outbreak, including 38 modified measles and 22 typical measles cases in its elimination era in Yamagata, Japan, 2017 publication-title: Jpn J Infect Dis doi: 10.7883/yoken.JJID.2018.083 – volume: 142 start-page: 1971 year: 1997 ident: 10.1016/j.jiac.2022.03.025_bib7 article-title: Development of a gelatin particle agglutination reagent for measles antibody assay publication-title: Arch Virol doi: 10.1007/s007050050215 – year: 2012 ident: 10.1016/j.jiac.2022.03.025_bib2 |
SSID | ssj0017588 |
Score | 2.3032506 |
Snippet | In regions where the endemic measles virus has been eliminated, early detection of contagious patients is important for preventing the spread of measles and... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1018 |
SubjectTerms | Antibodies, Viral Disease Outbreaks Gelatin particle agglutination Humans IgG avidity Immunoglobulin G Japan - epidemiology Measles - diagnosis Measles - epidemiology Measles - prevention & control Measles virus - genetics Plaque reduction neutralization Seroepidemiologic Studies Super-spreader Vaccine |
Title | A seroepidemiologic study of a measles outbreak, Yamagata Prefecture, Japan, 2017: The estimation of spreaders using serological assays in a measles elimination setting |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1341321X22001040 https://dx.doi.org/10.1016/j.jiac.2022.03.025 https://www.ncbi.nlm.nih.gov/pubmed/35396155 https://www.proquest.com/docview/2648896226 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELam8cIL4jflx2QktBcS2jixk_BWTUxliKkSm1SeLNuzp4wuqZb0oS_8PfyZ3NlJCxIMicdWvjrqne--yN99R8ibTBkmbGHirOA2zhLm4sIIOHhaYaejY9aTxz-fitl5drLgiz1yNPTCIK2yz_0hp_ts3X8z7v_N8aqqxl9QiixlyYIxLzKD7-1ZlmOUv_u-pXlAdfSzJ3FxjKv7xpnA8bqqFMoYMuaFTnFc9p-L09_Apy9Cx_fJvR490ml4wAdkz9YPyeE8yE9vInq266ZqI3pI5zth6s0j8mNKIeAauxsKWxnq9WVp46ii11a1S9vSZt3Bi7L6FtGv6lpdqk7ROY4j8bcNET2B-lpHFGp6_h53pCjUETog8Xfa1U2gR1Pk1F_6LfsESwGpq01Lq_qX3ezSDxbz5q31NOzH5Pz4w9nRLO4nNcQmK_Mu1i5xXDttnFNiosTF5AIqP1cJIDhjhC5Sk2sAhpxbnTGlkwLSKhNa5XkpFGDMJ2S_bmr7jFBj0xxnZqW8ALCkXVEmzgjOC2OgyBo-IsngIml6GXOcprGUA1_tSqJbJbpVTlIJbh2Rt1ubVRDxuHV1OnheDu2pkFAl1JhbrfjW6rcA_qfd6yG4JJxsvK5RtW3WrUTuYVEKwMcj8jRE3fbpU56WeKP8_D93fUHu4qfAO35J9rubtX0F6KrTB_74HJA704-fZqc_AVCNJZw |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEBZL9tBeSt9NnyqUvTQmsWzJdm9h6ZJ9hUCzkJ6EpJUW72btsHYO-Uf9mZ2R7aSFdgu92h7LeKSZT-ibbwj5FCvDhE1NEKfcBnHIXJAaAQtPK6x0dMx68vj5VEwu4pMFX-yRw64WBmmVbexvYrqP1u2VYfs3h6s8H35DKbKIhQvGvMgM7Nv3UZ2K98j--Ph0Mt0eJgAk9hVx8HyABm3tTEPzus4VKhky5rVOsWP2n_PT3_Cnz0NHj8mjFkDScfONT8ieLZ6Sg1mjQL0Z0PmuoKoa0AM622lTb56RH2MKc660u76wuaFeYpaWjip6a1W1tBUt1zXsldXNgH5Xt-pK1YrOsCOJP3AY0BNIscWAQlpPvuCIFLU6miJIfE-1umsY0hRp9Vd-yDbGUgDralPRvPhlNLv0vcW8eWU9E_s5uTj6Oj-cBG2zhsDEWVIH2oWOa6eNc0qMlLgcXULy5yoEEGeM0GlkEg3YkHOrY6Z0mEJkZUKrJMmEApj5gvSKsrCvCDU2SrBtVsRTwEvapVnojOA8NQbyrOF9EnYukqZVMseGGkvZUdauJbpVolvlKJLg1j75vLVZNToe9z4ddZ6XXYUqxFQJaeZeK761-m0O_9PuYze5JCxuPLFRhS3XlUT6YZoJgMh98rKZdduvj3iU4aHy6_8c9QN5MJmfn8mz4-npG_IQ7zQ05LekV9-t7TsAW7V-3y6mn0WNKE0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+seroepidemiologic+study+of+a+measles+outbreak%2C+Yamagata+Prefecture%2C+Japan%2C+2017%3A+The+estimation+of+spreaders+using+serological+assays+in+a+measles+elimination+setting&rft.jtitle=Journal+of+infection+and+chemotherapy+%3A+official+journal+of+the+Japan+Society+of+Chemotherapy&rft.au=Seto%2C+Junji&rft.au=Aoki%2C+Yoko&rft.au=Tanaka%2C+Shizuka&rft.au=Komabayashi%2C+Kenichi&rft.date=2022-07-01&rft.pub=Elsevier+Ltd&rft.issn=1341-321X&rft.volume=28&rft.issue=7&rft.spage=1018&rft.epage=1022&rft_id=info:doi/10.1016%2Fj.jiac.2022.03.025&rft.externalDocID=S1341321X22001040 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1341-321X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1341-321X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1341-321X&client=summon |